Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - PLUS THERAPEUTICS, INC. | ex31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - PLUS THERAPEUTICS, INC. | ex31_2.htm |
| EX-10.4 - EXHIBIT 10.4 - PLUS THERAPEUTICS, INC. | ex10_4.htm |
| 10-Q - CYTORI THERAPEUTICS, INC 10-Q 6-30-2015 - PLUS THERAPEUTICS, INC. | form10q.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350/ SECURITIES EXCHANGE ACT RULE 13a-14(b), AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Cytori Therapeutics, Inc. for the quarterly period ended June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof, Marc H. Hedrick, as President & Chief Executive Officer of Cytori Therapeutics, Inc., and Tiago Girao, as VP of Finance and Chief Financial Officer of Cytori Therapeutics, Inc., each hereby certifies, respectively, that:
| 1. | The Form 10-Q report of Cytori Therapeutics, Inc. that this certification accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934. |
| 2. | The information contained in the Form 10-Q report of Cytori Therapeutics, Inc. that this certification accompanies fairly presents, in all material respects, the financial condition and results of operations of Cytori Therapeutics, Inc. |
|
By:
|
/s/ Marc H. Hedrick
|
|
|
Dated: August 10, 2015
|
Marc H. Hedrick
|
|
|
President & Chief Executive Officer
|
||
|
By:
|
/s/ Tiago Girao
|
|
|
Dated: August 10, 2015
|
Tiago Girao
|
|
|
VP of Finance and Chief Financial Officer
|